Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
736
-
Total 13F shares, excl. options
-
242,696,353
-
Shares change
-
+13,286,835
-
Total reported value, excl. options
-
$9,853,287,513
-
Value change
-
+$527,077,666
-
Put/Call ratio
-
65.26%
-
Number of buys
-
321
-
Number of sells
-
-318
-
Price
-
$40.6
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q3 2017
831 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q3 2017.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 736 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 242,696,353 shares
.
Largest 10 shareholders include FMR LLC (19,898,632 shares), PRICE T ROWE ASSOCIATES INC /MD/ (16,708,263 shares), DODGE & COX (14,858,137 shares), Fisher Asset Management, LLC (12,828,251 shares), WELLS FARGO & COMPANY/MN (12,499,633 shares), STATE STREET CORP (10,312,810 shares), BANK OF AMERICA CORP /DE/ (10,129,639 shares), RENAISSANCE TECHNOLOGIES LLC (9,437,700 shares), ROYAL BANK OF CANADA (8,644,505 shares), and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8,416,927 shares).
This table shows the top 736 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.